{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:56:45Z","timestamp":1791946605305,"version":"4.3.4"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00316","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T23:28:41Z","timestamp":1582759721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":87,"title":["Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology"],"prefix":"10.3389","volume":"11","author":[{"given":"Stefan H. E.","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"B1","year":"","journal-title":"UN General Assembly High-Level Meeting on the Fight Against Tuberculosis."},{"key":"B2","author":"Calmette","year":"1927","journal-title":"La Vaccination Pr\u00e9ventive Contre La Tuberculose Par Le \u201cBCG\u201d."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ni1105-1063","article-title":"From bacteriology to immunology: the dualism of specificity.","volume":"6","author":"Kaufmann","year":"2005","journal-title":"Nat Immunol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The Efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.","author":"Colditz","year":"1995","journal-title":"Pediatrics."},{"key":"B5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis.","volume":"349","author":"Roy","year":"2014","journal-title":"Br Med J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S1473-3099(14)70852-7","article-title":"Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis.","volume":"14","author":"Chiang","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine."},{"key":"B9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B11","year":"2019","journal-title":"WHO Global Tuberculosis Report 2019."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018523","article-title":"Novel vaccination strategies against tuberculosis.","volume":"4","author":"Andersen","year":"2014","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41577-019-0174-z","article-title":"Moving tuberculosis vaccines from theory to practice.","volume":"19","author":"Andersen","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/14760584.2019.1593143","article-title":"Designing tuberculosis vaccine efficacy trials \u2013 lessons from recent studies.","volume":"18","author":"Ginsberg","year":"2019","journal-title":"Expert Rev Vaccines."},{"key":"B15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","article-title":"Future vaccination strategies against tuberculosis: thinking outside the box.","volume":"33","author":"Kaufmann","year":"2010","journal-title":"Immunity."},{"key":"B16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development.","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int J Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.smim.2013.04.006","article-title":"Tuberculosis vaccines: time to think about the next generation.","volume":"25","author":"Kaufmann","year":"2013","journal-title":"Semin Immunol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01203","article-title":"TBVAC2020: advancing tuberculosis vaccines from discovery to clinical development.","volume":"8","author":"Kaufmann","year":"2017","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis.","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/286079a0","article-title":"Ammonia inhibits phagosome-lysosome fusion in macrophages.","volume":"286","author":"Gordon","year":"1980","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells.","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/eji.201545493","article-title":"Versatile myeloid cell subsets contribute to tuberculosis-associated inflammation.","volume":"45","author":"Dorhoi","year":"2015","journal-title":"Eur J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: success through dormancy.","volume":"36","author":"Gengenbacher","year":"2012","journal-title":"FEMS Microbiol Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis.","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/S1472-9792(12)70007-0","article-title":"Ten challenges for TB biomarkers.","author":"Ottenhoff","year":"2012","journal-title":"Tuberculosis."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0010-2016","article-title":"Innate immune responses to tuberculosis.","volume":"4","author":"Schorey","year":"2016","journal-title":"Microbiol Spectr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.vaccine.2019.10.034","article-title":"Stopping live vaccines after disease eradication may increase mortality.","volume":"38","author":"Aaby","year":"2019","journal-title":"Vaccine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2018.12.006","article-title":"Innate and adaptive immune memory: an evolutionary continuum in the host\u2019s response to pathogens.","volume":"25","author":"Netea","year":"2019","journal-title":"Cell Host Microbe."},{"key":"B30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/eji.201343797","article-title":"Crosstalk between human DC subsets promotes antibacterial activity and CD8+ T-cell stimulation in response to Bacille Calmette-Guerin.","volume":"44","author":"Lozza","year":"2014","journal-title":"Eur J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1084\/jem.20100059","article-title":"Pulmonary dendritic cells: thinking globally, acting locally.","volume":"207","author":"Randall","year":"2010","journal-title":"J Exp Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.smim.2014.09.003","article-title":"Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.","volume":"26","author":"Behar","year":"2014","journal-title":"Semin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/path.1906","article-title":"New insights into the function of granulomas in human tuberculosis.","volume":"208","author":"Ulrichs","year":"2006","journal-title":"J Pathol."},{"key":"B35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin.","volume":"282","author":"Stenger","year":"1998","journal-title":"Science."},{"key":"B36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development.","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe."},{"key":"B37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41586-019-1276-2","article-title":"Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.","volume":"570","author":"Ardain","year":"2019","journal-title":"Nature."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01252","article-title":"IL-17 production from T helper 17, mucosal-associated invariant T, and \u03b3\u03b4 cells in tuberculosis infection and disease.","volume":"8","author":"Coulter","year":"2017","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/1873-3468.13488","article-title":"MAIT cells as attractive vaccine targets.","volume":"593","author":"Downey","year":"2019","journal-title":"FEBS Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis.","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41577-018-0028-0","article-title":"Antibodies and tuberculosis: finally coming of age?","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis.","volume":"167","author":"Lu","year":"2016","journal-title":"Cell."},{"key":"B43","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure.","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med."},{"key":"B44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41586-018-0439-x","article-title":"A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes.","volume":"560","author":"Roy Chowdhury","year":"2018","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis.","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1164\/rccm.201707-1475OC","article-title":"B cells producing Type I IFN modulate macrophage polarization in tuberculosis.","volume":"197","author":"Benard","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.101323","article-title":"IL-10-producing regulatory B cells and plasmocytes: molecular mechanisms and disease relevance.","volume":"44","author":"Cerqueira","year":"2019","journal-title":"Semin Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","article-title":"Tissue-resident T cells and other resident leukocytes.","volume":"37","author":"Masopust","year":"2019","journal-title":"Annu Rev Immunol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis.","volume":"7","author":"Perdomo","year":"2016","journal-title":"mBio."},{"key":"B50","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guerin \u0394urec::hly vaccine\u2019s superior protection against tuberculosis.","volume":"210","author":"Vogelzang","year":"2014","journal-title":"J Infect Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection.","volume":"18","author":"Simmons","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling.","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0006-2016","article-title":"Regulation of immunity to tuberculosis.","volume":"4","author":"Brighenti","year":"2016","journal-title":"Microbiol Spectr."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01895","article-title":"Monocytic myeloid-derived suppressor cells in chronic infections.","volume":"8","author":"Dorhoi","year":"2017","journal-title":"Front Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy.","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis following PD-1 blockade for cancer immunotherapy.","volume":"11","author":"Barber","year":"2019","journal-title":"Sci Transl Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/QCO.0000000000000367","article-title":"New concepts in understanding latent tuberculosis.","volume":"30","author":"Dodd","year":"2017","journal-title":"Curr Opin Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing.","volume":"20","author":"Lin","year":"2014","journal-title":"Nat Med."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection.","volume":"31","author":"Drain","year":"2018","journal-title":"Clin Microbiol Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1371\/journal.pmed.1002781","article-title":"Four-gene pan-African blood signature predicts progression to tuberculosis.","volume":"197","author":"Suliman","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07635-7","article-title":"Metabolite changes in blood predict the onset of tuberculosis.","volume":"9","author":"Weiner","year":"2018","journal-title":"Nat Commun."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study.","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/joim.12212","article-title":"Recent advances towards tuberculosis control: vaccines and biomarkers.","volume":"275","author":"Weiner","year":"2014","journal-title":"J Intern Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5588\/ijtld.17.0590","article-title":"Recurrent tuberculosis in the pre-elimination era.","volume":"22","author":"Rosser","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis.","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis.","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines.","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1080\/21645515.2019.1605817","article-title":"Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality.","volume":"15","author":"Kaufmann","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-med-042010-085643","article-title":"New paradigms for HIV\/AIDS vaccine development.","volume":"63","author":"Picker","year":"2012","journal-title":"Annu Rev Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat Med."},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-019-0113-9","article-title":"Boosting BCG with proteins or rAD5 does not enhance protection against tuberculosis in rhesus macaques.","volume":"4","author":"Darrah","year":"2019","journal-title":"NPJ Vaccines."},{"key":"B72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization.","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature."},{"key":"B73","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination.","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med."},{"key":"B74","first-page":"363","article-title":"Superiority of intravenously administered BCG and BCG cell walls in protecting rhesus monkeys (Macaca Mulatta) against airborne tuberculosis.","volume":"143","author":"Anacker","year":"1972","journal-title":"Z Immunitatsforsch Exp Klin Immunol."},{"key":"B75","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/IAI.2.5.574-582.1970","article-title":"Aerosol-induced tuberculosis in subhuman primates and the course of the disease after intravenous BCG vaccination.","volume":"2","author":"Barclay","year":"1970","journal-title":"Infect Immun."},{"key":"B76","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of quantiferon-TB gold in-tube conversion and reversion in a cohort of South African adolescents.","volume":"191","author":"Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J."},{"key":"B78","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-revac cluster-randomised trial.","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine."},{"key":"B80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi.","volume":"348","year":"1996","journal-title":"Lancet."},{"key":"B81","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-revac cluster-randomised trial.","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant Bacille Calmette-Guerin vaccine VPM1002: ready for clinical efficacy testing.","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol."},{"key":"B83","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis Bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin.","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial.","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa.","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin Vaccine Immunol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.PSIB-0029-2019","article-title":"ESX\/Type VII secretion systems-an important way out for mycobacterial proteins.","volume":"7","author":"Vaziri","year":"2019","journal-title":"Microbiol Spectr."},{"key":"B87","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.chom.2015.05.003","article-title":"Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1.","volume":"17","author":"Wassermann","year":"2015","journal-title":"Cell Host Microbe."},{"key":"B88","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.chom.2018.05.006","article-title":"The listeriolysin O pest-like sequence Co-opts AP-2-mediated endocytosis to prevent plasma membrane damage during listeria infection.","volume":"23","author":"Chen","year":"2018","journal-title":"Cell Host Microbe."},{"key":"B89","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.290.5493.992","article-title":"A pest-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity.","volume":"290","author":"Decatur","year":"2000","journal-title":"Science."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12988","article-title":"Listeriolysin O: a phagosome-specific cytolysin revisited.","volume":"21","author":"Nguyen","year":"2019","journal-title":"Cell Microbiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/infdis\/jiu675","article-title":"The recombinant BCG \u0394urec::hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation.","volume":"211","author":"Saiga","year":"2015","journal-title":"J Infect Dis."},{"key":"B92","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1016\/j.vaccine.2012.10.031","article-title":"The recombinant tuberculosis vaccine rBCG \u0394urec::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells.","volume":"30","author":"Farinacci","year":"2012","journal-title":"Vaccine."},{"key":"B93","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity."},{"key":"B94","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG \u0394urec hly+ induces superior protection over parental BCG by stimulating a balanced combination of Type 1 and Type 17 cytokine responses.","volume":"204","author":"Desel","year":"2011","journal-title":"J Infect Dis."},{"key":"B95","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM193709092171102","article-title":"First-infection type of tuberculosis in adults.","volume":"217","author":"Badger","year":"1937","journal-title":"N Engl J Med."},{"key":"B96","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7326\/0003-4819-33-4-941","article-title":"Tuberculosis in student nurses and medical students at the University of Wisconsin.","volume":"33","author":"Dickie","year":"1950","journal-title":"Ann Intern Med."},{"key":"B97","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/00039896.1968.10665011","article-title":"The epidemiology of tuberculosis infection in a closed environment.","volume":"16","author":"Houk","year":"1968","journal-title":"Arch Environ Health."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.19805.1","article-title":"Infection resisters: targets of new research for uncovering natural protective immunity against Mycobacterium tuberculosis.","volume":"8","author":"Kaipilyawar","year":"2019","journal-title":"F1000Research."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa4730","article-title":"Tuberculosis vaccines: time for a global strategy.","volume":"7","author":"Kaufmann","year":"2015","journal-title":"Sci Transl Med."},{"key":"B100","author":"Taleb","year":"2010","journal-title":"The Black Swan. The Impact of the Highly Improbable."},{"key":"B101","year":"2015","journal-title":"The Price of a Pandemic. Counting the Cost of MDR-TB."},{"key":"B102","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85a in healthy adults infected with HIV-1: a randomised, placebo-controlled, Phase 2 trial.","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B103","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled Phase 2b trial.","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002790","article-title":"Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: a Phase I randomised controlled trial.","volume":"16","author":"Manjaly Thomas","year":"2019","journal-title":"PLoS Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85a delivered by aerosol in BCG-vaccinated healthy adults: a Phase 1, double-blind, randomised controlled trial.","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human Type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity.","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Transl Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1586\/14760584.2014.929947","article-title":"Human Type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?","volume":"13","author":"Smaill","year":"2014","journal-title":"Expert Rev Vaccines."},{"key":"B108","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia ankara virus both expressing Ag85A.","volume":"33","author":"Stylianou","year":"2015","journal-title":"Vaccine."},{"key":"B109","doi-asserted-by":"crossref","first-page":"266","DOI":"10.18821\/0507-4088-2017-62-6-266-272","article-title":"Safety and immunogenicity of cold-adapted recombinant influenza vector expressing ESAT-6 and Ag85A antigens of M. tuberculosis.","volume":"62","author":"Sergeeva","year":"2017","journal-title":"Vopr Virusol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers.","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine."},{"key":"B111","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.vaccine.2015.05.036","article-title":"The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: a randomized controlled trial.","volume":"33","author":"Geldenhuys","year":"2015","journal-title":"Vaccine."},{"key":"B113","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine."},{"key":"B114","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1164\/rccm.201802-0366OC","article-title":"Dose optimization of H56:IC31 vaccine for tuberculosis-endemic populations. a double-blind, placebo-controlled, dose-selection trial.","volume":"199","author":"Suliman","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0057-5","article-title":"The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.","volume":"3","author":"Coler","year":"2018","journal-title":"NPJ Vaccines."},{"key":"B116","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2213-2600(18)30077-8","article-title":"Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled Phase 1 trial.","volume":"6","author":"Penn-Nicholson","year":"2018","journal-title":"Lancet Respir Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial.","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine."},{"key":"B118","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled Phase I trial.","volume":"3","author":"Spertini","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S2213-2600(19)30251-6","article-title":"Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.","volume":"7","author":"Tameris","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B120","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1086\/315393","article-title":"Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected Ugandan adults with newly diagnosed pulmonary tuberculosis. the Uganda-Case Western Reserve University research collaboration.","volume":"181","author":"Johnson","year":"2000","journal-title":"J Infect Dis"},{"key":"B121","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.1016\/j.vaccine.2010.09.041","article-title":"Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a Phase III study in Tanzania.","volume":"28","author":"Lahey","year":"2010","journal-title":"Vaccine."},{"key":"B122","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.","volume":"24","author":"von Reyn","year":"2010","journal-title":"AIDS."},{"key":"B123","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1097\/00002030-200311070-00010","article-title":"Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.","volume":"17","author":"Vuola","year":"2003","journal-title":"AIDS."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175215","article-title":"Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: a randomized, controlled trial of DAR-901.","volume":"12","author":"von Reyn","year":"2017","journal-title":"PLoS One."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039215","article-title":"Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung.","volume":"7","author":"Gupta","year":"2012","journal-title":"PLoS One."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMoa1407380","article-title":"Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.","volume":"371","author":"Mayosi","year":"2014","journal-title":"N Engl J Med."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03514-1","article-title":"Efficacy and safety of Mycobacterium indicus pranii as an adjunct therapy in category II pulmonary tuberculosis in a randomized trial.","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2217\/imt.13.110","article-title":"Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon Batch) formulated as an oral pill (V7).","volume":"5","author":"Butov","year":"2013","journal-title":"Immunotherapy."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001166","article-title":"Mycobacterium vaccae immunotherapy for treating tuberculosis.","volume":"2003","author":"de Bruyn","year":"2003","journal-title":"Cochrane Database Syst Rev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.4161\/hv.25280","article-title":"Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Longcom Batch) formulated as an oral pill (V7).","volume":"9","author":"Efremenko","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B131","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/br.2016.624","article-title":"Adjunctive therapy of Mycobacterium vaccae vaccine in the treatment of multidrug-resistant tuberculosis: a systematic review and meta-analysis.","volume":"4","author":"Weng","year":"2016","journal-title":"Biomed Rep."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023826","article-title":"Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis.","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One."},{"key":"B133","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection.","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis (Edinb)."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, tolerability, and immunogenicity of the novel antituberculous vaccine ruti: randomized, placebo-controlled Phase II clinical trial in patients with latent tuberculosis infection.","volume":"9","author":"Nell","year":"2014","journal-title":"PLoS One."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.vaccine.2009.09.134","article-title":"Double-blind, randomized, placebo-controlled Phase I clinical trial of the therapeutical antituberculous vaccine RUTI.","volume":"28","author":"Vilaplana","year":"2010","journal-title":"Vaccine."},{"key":"B136","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1016\/j.vaccine.2014.03.047","article-title":"Therapeutic vaccines for tuberculosis \u2013 a systematic review.","volume":"32","author":"Groschel","year":"2014","journal-title":"Vaccine."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00316\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T14:16:26Z","timestamp":1665929786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00316\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":136,"alternative-id":["10.3389\/fimmu.2020.00316"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00316","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"article-number":"316"}}